Clinical Results of Treatment of Diabetes Insipidus with Drugs of the Chlorothiazide Series
- 14 April 1960
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 262 (15) , 737-743
- https://doi.org/10.1056/nejm196004142621501
Abstract
DIABETES insipidus ordinarily is due to lack of the neurohypophyseal hormone, vasopressin, which enables the kidneys to form concentrated urine. Treatment consists of administering material obtained from animal sources intranasally, sublingually or intramuscularly. To control polyuria adequately with the first two routes, treatment must be repeated on the average four times daily whereas the preparation for intramuscular use, in which the hormone is tannated and suspended in oil, provides relief for approximately forty-eight hours. Less commonly, a nephrogenic type of the disease is encountered. Here, endogenous hormone is formed in abundance, but the kidney fails to respond to it. Moreover, . . .Keywords
This publication has 10 references indexed in Scilit:
- An Antimineralocorticoid Action of some Saluretic SulphonamidesNature, 1959
- A Clinical Study of the Effects of Hydrochlorothiazide on the Renal Excretion of Electrolytes and Free WaterNew England Journal of Medicine, 1959
- TREATMENT OF DIABETES INSIPIDUS WITH HYDROCHLOROTHIAZIDEThe Lancet, 1959
- Chlorothiazid in Diabetes InsipidusNature, 1959
- THROMBOCYTOPENIA DURING CHLOROTHIAZIDE TREATMENTThe Lancet, 1959
- Agranulocytosis with Thrombocytopenia following Chlorothiazide TherapyBMJ, 1958
- Jaundice Occurring in a Patient Treated with ChlorothiazideNew England Journal of Medicine, 1958
- EFFECT OF CHLOROTHIAZIDE ON ELECTROLYTE TRANSPORT IN MANJAMA, 1958
- Effect of a Mercurial Diuretic on the Excretion of “Free Water” in Diabetes InsipidusJournal of Applied Physiology, 1958
- THE "CARRIER" STATE IN NEPHROGENIC DIABETES INSIPIDUSThe Lancet, 1956